EP Patent

EP4574906A2 — Pharmaceutical composition

Assigned to MedinCell SA · Expires 2025-06-25 · 1y expired

What this patent protects

The present invention provides a biodegradable drug delivery composition comprising: (i) a mixture of at least three different block copolymers, wherein each block copolymer is: (a) a biodegradable triblock copolymer having the formula: A v − B w − A …

USPTO Abstract

The present invention provides a biodegradable drug delivery composition comprising: (i) a mixture of at least three different block copolymers, wherein each block copolymer is: (a) a biodegradable triblock copolymer having the formula: A v − B w − A x wherein A is a polyester and B is polyethylene glycol and v and x are the number of repeat units from 1 to 3,000 and w is the number of repeat units from 3 to 300 and v=x or v≠x; or (b) a biodegradable diblock copolymer having the formula: C y − A z wherein A is a polyester and C is an end-capped polyethylene glycol and y and z are the number of repeat units with y = 2 to 250 and z = 1 to 3,000; and wherein the mixture comprises at least one (a) and at least one (b); and the weight ratio between (a) and (b) is 1:19 to 5:1; and (ii) at least one pharmaceutically active ingredient.

Drugs covered by this patent

Patent Metadata

Patent number
EP4574906A2
Jurisdiction
EP
Classification
Expires
2025-06-25
Drug substance claim
No
Drug product claim
No
Assignee
MedinCell SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.